⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IMNN News
Imunon, Inc. Common Stock
IMUNON to Participate in Upcoming Investor Conferences
globenewswire.com
IMNN
Form 8-K
sec.gov
IMNN
IMUNON Converts $1.2 Million of Debt-to-Equity
globenewswire.com
IMNN
IMUNON Makes the Frontline Case for Phase 3 IMNN-001 Study: 14.7-Month OS Signal, Historical IL-12 Safety Barriers Overcome, Enrolling Ahead of Plan
globenewswire.com
IMNN
IMUNON Reports Independent Data Monitoring Committee Recommends Continued Phase 2 Development of IMNN-001 Following Favorable Safety Review
globenewswire.com
IMNN
IMUNON Enters Cooperative Research and Development Agreement with National Cancer Institute to Advance Clinical Development of IMNN-001
globenewswire.com
IMNN
IMUNON Announces Full Agenda and Speaker Lineup Ahead of 2026 R&D Day Highlighting IMNN-001 Clinical Progress
globenewswire.com
IMNN
IMUNON to Host 2026 R&D Day Highlighting Phase 3 OVATION 3 Trial and the Clinical Potential of IMNN-001
globenewswire.com
IMNN
Form 8-K
sec.gov
IMNN
Form 8-K
sec.gov
IMNN